SHIFT Newsroom · UK
Bolt Pharmacy: ASA ruling on Facebook weight-loss ads
The ASA upheld two issues on 29 July 2026.
What the ASA found
On 29 July 2026, the ASA ruled against two Facebook advertisements placed through UK Weight Loss Reviews, operated by Bolt Pharmacy. It found that their commercial purpose was unclear and that they promoted prescription-only medicines to the public.
Bolt’s response
Bolt acknowledged the presentation could mislead readers. It said the ads had stopped and that its marketing and customer journeys had changed.
What the ruling covers
The decision concerns those advertisements, not a medicine recall or a general finding about clinical care.
Read the original ASA ruling. See our [editorial standards](/editorial-standards) and [newsroom](/shift-newsroom).
What this means in the UK
Readers should distinguish advertising from independent reviews.
Known facts
- Two issues upheld.